Journal of Hematology & Oncology

official impact factor 2.93
Search for
Advanced search
Journal of Hematology & Oncology
Tools
Share this article
Open Access Highly Access

Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP

Yuan Yuan, Yu-Min Liao, Chung-Tsen Hsueh and Hamid R Mirshahidi*

Journal of Hematology & Oncology 2011, 4:16 doi:10.1186/1756-8722-4-16

Accesses  

  • Last 30 days: 324 accesses
  • Last 365 days: 5812 accesses
  • All time: 6615 accesses

Cited by

BioMed Central: 2 citations

Research   Open Access

Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression

David Z Chang, Ying Ma, Baoan Ji, Yan Liu, Patrick Hwu, James L Abbruzzese, Craig Logsdon, Huamin Wang Journal of Hematology & Oncology 2012, 5:15 (4 April 2012)

Abstract | Full text | PDF | PubMed

Review   Open Access Highly Accessed

Current management and novel agents for malignant melanoma

Byung Lee, Nikhil Mukhi, Delong Liu Journal of Hematology & Oncology 2012, 5:3 (14 February 2012)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Google Scholar: View citations

ISI Web of Science: View citations

PubMed Central: View citations